81 related articles for article (PubMed ID: 21647888)
1. Analytical characterization of a novel degradation product in a PEGylated recombinant protein.
Zhang B; Towers EW; Poppe L; Cockrill SL
J Pharm Sci; 2011 Nov; 100(11):4607-16. PubMed ID: 21647888
[TBL] [Abstract][Full Text] [Related]
2. Characterization of potential degradation products in a PEGylating reagent 20 kDa monomethoxy polyethylene glycol propionaldehyde by RP-HPLC, APCI-MS and NMR.
Zhang H; Wilson J; Zhang J; Luo Y
J Pharm Biomed Anal; 2014 Feb; 89():221-6. PubMed ID: 24316423
[TBL] [Abstract][Full Text] [Related]
3. Novel polyethylene glycol derivative suitable for the preparation of mono-PEGylated protein.
Yun Q; Chen T; Zhang G; Bi J; Ma G; Su Z
Biotechnol Lett; 2005 Feb; 27(3):213-7. PubMed ID: 15717132
[TBL] [Abstract][Full Text] [Related]
4. Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin.
Nie Y; Zhang X; Wang X; Chen J
Bioconjug Chem; 2006; 17(4):995-9. PubMed ID: 16848407
[TBL] [Abstract][Full Text] [Related]
5. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
[TBL] [Abstract][Full Text] [Related]
6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
7. Solid phase pegylation of hemoglobin.
Suo X; Zheng C; Yu P; Lu X; Ma G; Su Z
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(4):147-55. PubMed ID: 19526439
[TBL] [Abstract][Full Text] [Related]
8. Separation of exenatide analogue mono-PEGylated with 40 kDA polyethylene glycol by cation exchange chromatography.
Cai Y; Yue P
J Chromatogr A; 2011 Sep; 1218(39):6953-60. PubMed ID: 21862025
[TBL] [Abstract][Full Text] [Related]
9. Precise and comparative pegylation analysis by microfluidics and mass spectrometry.
Yu T; Traina JA; Pungor E; McCaman M
Anal Biochem; 2006 Dec; 359(1):54-62. PubMed ID: 17010928
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Ganoderma lucidum immunomodulatory protein modified with polyethylene glycol.
Zhang X; Sun F; Liu Z; Zhang S; Liang C
Mol Med Rep; 2013 Mar; 7(3):975-80. PubMed ID: 23338950
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase.
Wang J; Hu T; Liu Y; Zhang G; Ma G; Su Z
Anal Biochem; 2011 May; 412(1):114-6. PubMed ID: 21185800
[TBL] [Abstract][Full Text] [Related]
12. Effect of pegylation on self-association of IFN-α2b.
Mohs A; Ambrogelly A; Yang X; Haverick M; Cheung JK; Narasimhan C; Shameem M
Mol Pharm; 2014 Jan; 11(1):158-63. PubMed ID: 24266549
[TBL] [Abstract][Full Text] [Related]
13. Ultrafiltration characteristics of pegylated proteins.
Molek JR; Zydney AL
Biotechnol Bioeng; 2006 Oct; 95(3):474-82. PubMed ID: 16736533
[TBL] [Abstract][Full Text] [Related]
14. Novel Bioconjugation Strategy Using Elevated Hydrostatic Pressure: A Case Study for the Site-Specific Attachment of Polyethylene Glycol (PEGylation) of Recombinant Human Ciliary Neurotrophic Factor.
Wang Q; Zhang C; Guo F; Li Z; Liu Y; Su Z
Bioconjug Chem; 2017 Nov; 28(11):2841-2848. PubMed ID: 29053917
[TBL] [Abstract][Full Text] [Related]
15. Analytical and preparative separation of PEGylated lysozyme for the characterization of chromatography media.
Moosmann A; Christel J; Boettinger H; Mueller E
J Chromatogr A; 2010 Jan; 1217(2):209-15. PubMed ID: 19963219
[TBL] [Abstract][Full Text] [Related]
16. Separation and detection of bis-maleimide-polyethylene glycol and mono-maleimide-polyethylene glycol by reversed-phase high pressure liquid chromatography.
Tang L; Jariwala F; Bolgar M; Lloyd DK
J Chromatogr A; 2012 Jul; 1246():117-22. PubMed ID: 22503616
[TBL] [Abstract][Full Text] [Related]
17. PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor.
Guerra PI; Acklin C; Kosky AA; Davis JM; Treuheit MJ; Brems DN
Pharm Res; 1998 Dec; 15(12):1822-7. PubMed ID: 9892464
[TBL] [Abstract][Full Text] [Related]
18. Correlations between in vitro potency of polyethylene glycol-protein conjugates and their chromatographic behavior.
Caserman S; Kusterle M; Kunstelj M; Milunović T; Schiefermeier M; Jevsevar S; Porekar VG
Anal Biochem; 2009 Jun; 389(1):27-31. PubMed ID: 19306838
[TBL] [Abstract][Full Text] [Related]
19. Identification of a yellow impurity in aged samples of aqueous butamben suspension: evidence for the oxidative degradation of poly(ethylene glycol).
Ginsburg EJ; Stephens DA; West PR; Buko AM; Robinson DH; Li LC; Bommireddi AR
J Pharm Sci; 2000 Jun; 89(6):766-70. PubMed ID: 10824135
[TBL] [Abstract][Full Text] [Related]
20. Plain and mono-pegylated recombinant human insulin exhibit similar stress-induced aggregation profiles.
Torosantucci R; Kukrer B; Mero A; Van Winsen M; Tantipolphan R; Jiskoot W
J Pharm Sci; 2011 Jul; 100(7):2574-85. PubMed ID: 21344414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
